{{brizy_dc_image_alt imageSrc=
Join/ Subscribe Us

Subscribe

We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox..





    We assure a spam-free experience. You can update your email preference or unsubscribe at any time and we'll never share your information without your consent. Click here for Privacy Policy.


    Safe and Secure

    Free Articles

    {{brizy_dc_image_alt imageSrc=
    Join/ Subscribe Us

    Subscribe

    We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox.





      We assure a spam-free experience. You can update your email preference or unsubscribe at any time and we'll never share your information without your consent. Click here for Privacy Policy.


      Safe and Secure

      Free Articles

      HealthTech

      KnowledgeNile is the one of the emerging technology content marketing organizations. 

      {{brizy_dc_image_alt entityId=
      OneMedNet Announces Exciting New Collaboration with Bayer’s AI Innovation Platform to Help Accelerate Healthcare AI Development
      MINNEAPOLIS, (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products. "We […]
      {{brizy_dc_image_alt entityId=
      Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset
      Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset Research presented at British Thoracic Society Winter Meeting demonstrates potential for revolutionary shift in respiratory care Technology set to transform respiratory clinical trials: single device delivers continuous endpoint data across multiple parameters with minimal patient burden OXFORD, UK; […]
      {{brizy_dc_image_alt entityId=
      Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows
      Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its strategic collaboration with Amazon Web Services (AWS) to offer Philips’ integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology [1], and AI advanced visualization [1] solutions. The collaboration aims to unify […]
      {{brizy_dc_image_alt entityId=
      PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
      MENLO PARK, Calif., (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first benchtop long-read sequencing platform. Vega delivers all the functionality of the Revio system, PacBio’s high-throughput long-read sequencer, into a compact, lower-throughput benchtop platform. Offering exceptional data accuracy with HiFi technology, […]
      {{brizy_dc_image_alt entityId=
      Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
      Business Wire India Boomi™, the intelligent integration and automation leader, today announced a partnership with BASE life science (BASE), an Infosys company and managed services provider that specializes in optimizing the use of cloud-based systems for the life sciences industry. Expanding upon Boomi’s existing partnership with Infosys, together BASE and Boomi are enhancing integration capabilities […]
      {{brizy_dc_image_alt entityId=
      Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations
      New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients FRANKLIN, Tenn., (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment […]
      {{brizy_dc_image_alt entityId=
      Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
      CAMBRIDGE, Mass.,(GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that its stockholders voted to approve the previously announced proposed sale of the Company’s VOWST business to Société des Produits Nestlé S.A. Seres will file a Current Report on Form 8-K with the SEC which […]
      {{brizy_dc_image_alt entityId=
      Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion
      Business Wire India Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024. This strategic appointment is part of Novotech's ongoing efforts to expand its global footprint and enhance […]
      {{brizy_dc_image_alt entityId=
      CHMP has adopted a negative opinion on lecanemab for the EU
      STOCKHOLM, July 26, 2024 -- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has today communicated that it has adopted a negative opinion on BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai's Marketing Authorization Approval (MAA) for lecanemab as treatment for Alzheimer's disease. BioArctic is currently consulting […]
      {{brizy_dc_image_alt entityId=
      Greenwich LifeSciences Set to Join Russell 2000 Index Again
      STAFFORD, Texas, June 26, 2024 -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that it is set to join the Russell 2000 and Russell 3000 Indexes at the conclusion of […]
      Scroll to Top